REQUEST A DEMO
Total
USD $0.00
Search more companies

Caliway Biopharmaceuticals Co., Ltd. (康霈生技股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Caliway Biopharmaceuticals Co., Ltd. Profile Updated: March 17, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Caliway Biopharmaceuticals Co., Ltd. (康霈生技股份有限公司) is a company in Taiwan, China, with a head office in New Taipei City. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on October 22, 2012. 41 (2023) employees currently work for Caliway Biopharmaceuticals Co., Ltd. (康霈生技股份有限公司). There was a net sales revenue drop of 14.4% reported in Caliway Biopharmaceuticals Co., Ltd. (康霈生技股份有限公司)’s latest financial highlights for 2025. During that time, Caliway Biopharmaceuticals Co., Ltd. (康霈生技股份有限公司)’s total assets decreased by 3.03%. In, 2025, the company’s net profit margin increased by 399.98%.

Headquarters
32F-9, No.99, Sec. 1, Xintai 5Th Rd., Xizhi Dist
New Taipei City; New Taipei City;

Contact Details: Purchase the Caliway Biopharmaceuticals Co., Ltd. (康霈生技股份有限公司) report to view the information.

Website: http://www.caliwaybiopharma.com

Basic Information
Total Employees:
Purchase the Caliway Biopharmaceuticals Co., Ltd. (康霈生技股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Caliway Biopharmaceuticals Co., Ltd. (康霈生技股份有限公司) report to view the information.
Financial Auditors:
Purchase the Caliway Biopharmaceuticals Co., Ltd. (康霈生技股份有限公司) report to view the information.
Incorporation Date:
October 22, 2012
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Finance Officer
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
9.85%
Purchase this report to view the information.
6.95%
Purchase this report to view the information.
4.31%
Purchase this report to view the information.
3.2%
Purchase this report to view the information.
3.18%
Subsidiaries
Cailway (Usa)Co.,Ltd (United States)
100%
Caliway Biopharmaceuticals Australia Pty Ltd (Australia)
100%
Caliway Biopharmaceuticals Czech, S.R.O. (Czech Republic)
100%
Company Performance
Financial values in the chart are available after Caliway Biopharmaceuticals Co., Ltd. (康霈生技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-14.4%
Total Operating Revenue
-36.93%
Operating Profit
-0.88%
EBITDA
-0.72%
Net Profit/Loss for the Period
40.23%
Total Assets
-3.03%
Total Equity
-2.95%
Operating Profit Margin
-281.76%
Net Profit Margin
399.98%
Return on Equity (ROE)
2.33%
Debt / Equity
-90%
Quick Ratio
-74322.17%
Cash Ratio
-113.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?